For veterans diagnosed with Post Traumatic Stress Disorder (PTSD) and looking for alternative ways to treat it, the first FDA-regulated study on the benefits of smoked cannabis yielded favorable results this year.
In a placebo-controlled, double-blind study published on March 17 in PLOS ONE, the peer-reviewed journal specified levels of improvement among participants using smoked cannabis blends with a 9 percent THC concentration.
The Multidisciplinary Association for Psychedelic Studies (MAPS), a San Jose, Calif.-based, nonprofit founded in 1986 to raise awareness and understanding of psychedelic substances, conducted the study. In it, the research showed improvements in samples containing 11 percent CBD, as well as mixed samples containing 8 percent of both THC and CBD.
โThis study served as the first randomized placebo-controlled trial comparing the therapeutic potential of varying ratios of THC and CBD for treating symptoms of PTS,โ said Dr. Marcel
O. Bonn-Miller, lead author of the study.
Click here to read the full article